Tuesday, August 31, 2010 12:47:59 PM
From the status report:
Cancer Drug Delivery System Patent Portfolio Development: The Company has completed the proposed product risk analysis and preliminary history on the now patented advanced liquid drug delivery system for chemotherapy and other drugs, and has engaged an FDA consultant to develop an FDA 510K application. Part of the process will involve advancing from demonstrative prototypes to production prototypes.
My opinions are just that. OPINIONS. I am no expert in trading, stocks, of ANY kind. I post what I believe is to be true. I share what's on my mind and think for yourself. My opinions can be incorrect at times. Do your own DD. Don't take my, or others, op
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM